Skip to main content
Clinical Trials/NCT01242358
NCT01242358
Unknown
Phase 3

Clinical Value of Advanced Patient Monitoring Using Capnography With Analysis of the Integrated Pulmonary Index During Percutaneous Endoscopic Gastrostomy.

Ruhr University of Bochum3 sites in 1 country170 target enrollmentJune 2010

Overview

Phase
Phase 3
Intervention
Not specified
Conditions
In the Study the Value of Capnography for Avoiding Complications During Sedation for PEG is Evaluated.
Sponsor
Ruhr University of Bochum
Enrollment
170
Locations
3
Primary Endpoint
Hypoxemia
Last Updated
14 years ago

Overview

Brief Summary

In this randomized controlled trial the utility of capnography gets evaluated. Hypoxemia may occur during sedation with midazolam and propofol. Whether hypoxemia may be prevented by an additional capnographic monitoring is subject of the study.

Registry
clinicaltrials.gov
Start Date
June 2010
End Date
March 2012
Last Updated
14 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Ruhr University of Bochum
Responsible Party
Principal Investigator
Principal Investigator

Andrea Riphaus

Clinical value of capnography During Percutaneous Endoscopic Gastrostomy (PEG)

Ruhr University of Bochum

Eligibility Criteria

Inclusion Criteria

  • 18 Years and older
  • Scheduled for PEG with propofol sedation

Exclusion Criteria

  • No informed consent
  • Emergency endoscopy
  • Preexisting hypotension, bradycardia or hypoxemia

Outcomes

Primary Outcomes

Hypoxemia

Time Frame: From the beginning to the end of the PEG procedure, i.e. from 0h to approximately 2h

Secondary Outcomes

  • Further complications(From the beginning to the end of the PEG procedure, i.e. from 0h to approximately 2h)

Study Sites (3)

Loading locations...

Similar Trials